findmyKOL

Paul Croarkin, DO

Enriched profile

Professor of Pediatrics, Pharmacology, and Psychiatry; Ervin A. and Margaret C. Mueller Director of Mayo Clinic Children's Research Center · Mayo Clinic

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyPsychiatryFocusTranscranial Magnetic Stimulation Studies+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2021NIH funding2014–2023

Paul Croarkin is Professor of Pediatrics, Pharmacology, and Psychiatry; Ervin A. and Margaret C. Mueller Director of Mayo Clinic Children's Research Center at Mayo Clinic. OpenAlex indexes 492 publications with 7,532 citations (h-index 48); ClinicalTrials.gov lists 11 registered studies with this person as an investigator.

Data verified 20 Oct 2026

Overview

Updated 23 Oct 2026

Paul Croarkin, D.O., is Professor of Pediatrics, Pharmacology, and Psychiatry at Mayo Clinic, Rochester, Minnesota. The public record shows 492 publications with 7,532 citations (h-index 48), centered on Transcranial Magnetic Stimulation Studies, Treatment of Major Depression, Electroconvulsive Therapy Studies. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 1 companies, 3 NIH-funded awards (2014–2023).

  • Most recent indexed publication: 2026 · medRxiv
  • Top research focus: Transcranial Magnetic Stimulation Studies
  • 11 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Depression (MDD)10 trialsMajor Depressive Disorder8 trialsOppositional Defiant Disorder1 trialEpilepsy1 trialEpilepsy, Generalized1 trial

Research focus

OpenAlex concept fingerprint
Transcranial Magnetic Stimulation StudiesTreatment of Major DepressionElectroconvulsive Therapy StudiesChild and Adolescent Psychosocial and Emotional DevelopmentNeurological disorders and treatments

Works with

trial sponsors and companies reporting payments
Mayo ClinicClinical trials7Industry payments—Paul E. CroarkinClinical trials3Industry payments—NeuroneticsClinical trials1Industry payments—Sunovion Pharmaceuticals Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
492publications

Distinct works indexed by OpenAlex, matched via ORCID; 66 in PubMed.

7,532citations

Total citations across indexed works.

48h-index

Hirsch index (OpenAlex). i10-index 162.

Clinical & industry

trials, payments and federal funding
11clinical trials

Investigator role on registered studies.

View trials ↓
1companies · 2021–2021

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
3NIH grants · 2014–2023

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 23 Oct 2026

Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 23 Oct 2026

1 company reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    100%
    alpha-Adrenergic Blocker100%
    Prazosin Hcl100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 23 Oct 2026

3 NIH research awards on record, funded 2014–2023 per NIH RePORTER. The latest:

Publications

Updated 23 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 23 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jennifer L. Vande Voort63Magdalena Romanowicz59Zafiris Jeff Daskalakis37Arjun P. Athreya35Paul A. Nakonezny34Mark A. Frye34Julia Shekunov33Daniel M. Blumberger32Simon Kung31William Victor Bobo31Jeffrey Robert Strawn30Charles P. Lewis29Stephanie Hope Ameis20Joanna M. Biernacka20Deniz Doruk Camsari19Marin Veldić19Graham J. Emslie18Maria I. Lapid18Jennifer R. Geske18Scott T. Aaronson18Taryn L. Mayes17Frank P. MacMaster17Ayse Irem Sonmez17John D. Port16Faranak Farzan16Can Özger16Juan Felipe Garzon16Gregory A. Worrell15Frank Andrew Kozel14Richard M. Weinshilboum14Péter Szatmári13Çiçek Nur Bakır13Brian N. Lundstrom13Mustafa M. Husain12Balwinder Singh12Meng‐Chuan Lai12Michelle K. Skime12Reem M.A. Shafi12Adam Kirton12Aiswarya Laks Nandakumar11

Online presence

Updated 23 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/paul-croarkin-do

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    childmind.org/event/visiting-professor-lecture-series-recent-advances-in-noninvasive-brain-stimulation-paul-croarkin-do-ms

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →childmind.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 23 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Editor-in-Chief

    Journal of Child and Adolescent Psychopharmacology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →home.liebertpub.com ↗
  • Distinguished Fellow

    American Psychiatric Association

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗

Awards & honors

honors on the public record

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.